Topics covered: Traditional Chinese Medicine VS. Western Medicine In Chinese Pharma, Stem Cell-Based Technology, Small-Cap Specialty Pharma, Pending Health Care Reform, Patent Expiration, Indian Pharma VS. U.S. Pharma, FDA Approval Process, Expansion Into Asian Markets, Cultivating And Expanding R&D Pipelines, Competition From Generics, Clinical Research Outsourcing Market, Chinese Drug Manufacturers, Cancer Radiation Therapy, Brisk M&A Activity